Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: Clinical course and prognostic significance

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 3, 2009, Pages 273-278

  Kharitonova, T ^a   Thoren M ^a   Ahmed, N ^a   Wardlaw, J M ^b   Von Kummer, R ^c   Thomassen, L ^d   Wahlgren, N ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; CEREBRAL ARTERY DISEASE; COHORT ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; PROGNOSIS; RADIOGRAPHY; REGISTER;

AGED; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61549096231     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.150185     Document Type: Article

References (27)

1. Bastianello S, Pierallini A, Colonnese C, et al. Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. Neuroradiology 1991;33:207-11.
2. Leys D, Pruvo JP, Godefroy 0, er al. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke 1992;23:317-24.
3. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3-13.
4. von Kummer R, Meyding-Lamade U, Forsting M, et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 1994;15:9-15.
5. Garg N, Eshkar N, Tanenbaum L, et al. Computed tomography angiographic correlates of early computed tomography signs in acute ischemic stroke. J Neuroimaging 2004;14:242-5.
6. Tsao JW, Gean AD, Glenn OA, et al. Hyperdense MCA resolved after tPA. Neurology 2002;58:1512.
7. Muir KW, Ruchan A, von Kummer R, et al. Imaging of acute stroke. Lancet Neurol 2006;5:755-68.
8. Moulin T, Cattin F, Crepin-Leblond T, et al. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology 1996;47:366-75.
9. Koga M, Saku Y, Toyoda K, et al. Reappraisal of early CT signs to predict the arterial occlusion site in acute embolic stroke. J Neurol Neurosurg Psychiatry 2003;74:649-53.
10. Wardlaw JM, Mielke 0. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment-systematic review. Radiology 2005;235:444-53.
11. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNH Am J Neuroradiol 1996;17:79-85.
12. Manelfe C, Larrue V, von Kummer R, et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 1999;30:769-72.
13. Qureshi Al, Ezzeddine MA, Nasar A, et al. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology 2006:66:1171-4.
14. Derex L, Hermier M, Adeleine P, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry 2005;76:70-5.
15. Khatri P, Wechsler LR, Rroderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke 2007;38:431- 40.
16. Mattle HP, Arnold M, Georgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379-83.
17. Bendszus M, Urbach H, Ries F, et al. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology 1998;40:54-8.
18. Agarwal P, Kumar S, Hariharan S, et al. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Cerebrovasc Dis 2004;17:182-90.
19. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-M0ST): an observational study. Lancet 2007;369:275-82.
20. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-6.
21. Brown DL, Johnston KC, Wagner DP, et al. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activatr treatment of stroke. Stroke 2004;35:147-50.
22. Kharitonova T, Thorén M, Ahmed N, et al. Disappearance of hyperdense middle cerebral artery sign (HMCAS) after i.v. thrombolysis-results from 1.737 patients in the SITS database. Cerebrovasc Dis 2007;23(Suppl 2, European Stroke Conference) :38.
23. Fisher M, Adams RD. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 1951 ;10:92-4.
24. Tomsick TA, Rrott TG, Olinger CP, et al. Hyperdense middle cerebral artery: incidence and quantitative significance. Neuroradiology 1989;31:312-15.
25. Molina CA, Alvarez-Sabin J, Montaner J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002;33:1551-6.
26. Kirchhof K, Welzel T, Mecke C, et al. Differentiation of white, mixed, and red thrombi: value of CT in estimation of the prognosis of thrombolysis phantom study. Radiology 2003;228:126-30.
27. Rubiera M, Ribo M, Delgado-Mederos R, et al. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis. Stroke 2006;37:2301-5.